Pallas Capital Advisors LLC Sana Biotechnology, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.71 Billion
- Q4 2025
A detailed history of Pallas Capital Advisors LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 39,627 shares of SANA stock, worth $158,111. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,627
Previous 39,627
-0.0%
Holding current value
$158,111
Previous $140,000
12.86%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SANA
# of Institutions
196Shares Held
121MCall Options Held
194KPut Options Held
353K-
Flagship Pioneering Inc. Cambridge, MA25MShares$99.8 Million32.83% of portfolio
-
Black Rock Inc. New York, NY11MShares$44.1 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$40.6 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.13MShares$36.4 Million0.0% of portfolio
-
State Street Corp Boston, MA6.68MShares$26.7 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $759M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...